Management of liver metastases of gastrointestinal stromal tumor.
- Author:
Chun-yi HAO
1
;
Hong-gang QIAN
Author Information
1. Department of Hepato-Pancreatico-Biliary Surgery, Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Beijing Cancer Hospital and Institute, Peking University School of Oncology, Beijing 100142, China. haochunyi@gmail.com
- Publication Type:Journal Article
- MeSH:
Gastrointestinal Stromal Tumors;
pathology;
therapy;
Humans;
Liver Neoplasms;
secondary;
therapy
- From:
Chinese Journal of Gastrointestinal Surgery
2012;15(3):221-224
- CountryChina
- Language:Chinese
-
Abstract:
Liver is the most common metastatic site of gastrointestinal stromal tumor(GIST). The recurrence rate is high even after hepatectomy. Although tyrosine kinase inhibitors (TKI) makes the resection feasible for some of the liver metastasis of GIST and significantly increase the overall survival, surgery still can not be substituted. Therefore, it is worth investigating and exploring the most appropriate treatment for the GIST with liver metastasis.
